Event details

Nova Eye Medical - Innovative Glaucoma Treatments

Nova Eye Medical Limited

Nova Eye Medical is a pioneering medical technology company dedicated to advancing the treatment of glaucoma across the full patient journey. Grounded in close collaboration with leading ophthalmic surgeons worldwide, the company designs, develops, and commercialises innovative surgical solutions shaped by real-world clinical practice. Their core philosophy centers on providing intuitive, tissue-preserving, and physiological options that seamlessly integrate into the surgical workflow while optimizing patient outcomes. At the forefront of Nova Eye’s product portfolio is the iTrack™ Advance, an illuminated microcatheter featuring an ergonomic handpiece engineered to support angle-based minimally invasive glaucoma surgery (MIGS) and canaloplasty. Building upon the proven track record of the original iTrack™ system, which has been used in more than 150,000 procedures globally, the platform allows surgeons to precisely catheterise and viscodilate Schlemm's canal. For more severe and complex glaucoma cases, the company also offers the Molteno3® drainage device, ensuring clinicians are equipped across the spectrum of disease severity. What truly distinguishes Nova Eye in the ophthalmic landscape is its strong commitment to restoring natural, physiological outflow without the need for permanent stent implants or unnecessary tissue destruction. Innovations such as their proprietary Shear Clear™ technology further refine procedures by optimising viscoelastic delivery during canaloplasty. Backed by a prominent network of global surgeon partners and regular presentations at major international congresses, Nova Eye continues to drive the mainstream adoption of interventional glaucoma, empowering physicians to deliver safer, highly repeatable, and effective care.